Volixibat
id:
volixibat-311-1168391
title:
Volixibat
text:
Volixibat is a medication under development as a possible treatment for nonalcoholic steatohepatitis (NASH), the most severe form of non-alcoholic fatty liver disease (NAFLD). No other pharmacotherapy yet exists for NASH, so there is interest in whether volixibat can prove to be both safe and effective. To encourage development and testing, the U.S. Food and Drug Administration (FDA) has issued fast track status. Volixibat is an IBAT inhibitor, meaning that it blocks the function of the IBAT pro
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Volixibat
date created:
date modified:
2024-03-05T03:06:23Z
main entity:
{"identifier":"Q27293432","url":"https://www.wikidata.org/entity/Q27293432"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/2/2b/Volixibat_structure.svg","width":512,"height":252}
fields total:
13
integrity:
15